FEATURES OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA TREATED IN A SPECIFIC LIPID UNIT

被引：0
|
作者：
Gonzalez Molero, I. [1 ]
Vallejo, R. [1 ]
Omiste, A. [1 ]
Dominguez Lopez, M. [1 ]
Gonzalo Marin, M. [1 ]
Olveira, G. [1 ]
Tinahones, F. [1 ]
机构：
[1] Carlos Haya Hosp, Malaga, Spain
来源：
ATHEROSCLEROSIS | 2014年 / 235卷 / 02期
关键词：
D O I：
10.1016/j.atherosclerosis.2014.05.584
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EAS-0800
引用
收藏
页码：E197 / E198
页数：2
相关论文
共 50 条
  • [31] Lipid and antioxidant system in children with familial hypercholesterolemia
    Pietraszek, E
    Kubalska, J
    Socha, P
    Skorapa, E
    Kowalik, A
    Wawer, ZT
    Wierzbicka, A
    CLINICA CHIMICA ACTA, 2005, 355 : S302 - S303
  • [32] Usefulness of Lipid Apheresis in the Treatment of Familial Hypercholesterolemia
    Lui, Matthew
    Garberich, Ross
    Strauss, Craig
    Davin, Thomas
    Knickelbine, Thomas
    JOURNAL OF LIPIDS, 2014, 2014
  • [33] Referral rate, profile and degree of control of patients with familial hypercholesterolemia: data from a single lipid unit from a Mediterranean area
    Serra-Planas, Enric
    LIPIDS IN HEALTH AND DISEASE, 2023, 22 (01)
  • [34] DETECTION OF COMORBIDITIES IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN THE UKRAINIAN FAMILIAL HYPERCHOLESTEROLEMIA REGISTRY
    Chulaievska, N.
    Mitchenko, O.
    Romanov, V.
    Timokhova, K.
    ATHEROSCLEROSIS, 2022, 355 : E223 - E223
  • [35] Referral rate, profile and degree of control of patients with familial hypercholesterolemia: data from a single lipid unit from a Mediterranean area
    Enric Serra-Planas
    Lipids in Health and Disease, 22
  • [36] Effectiveness and Safety of Lipid-Lowering Drug Treatments in Japanese Patients with Familial Hypercholesterolemia: Familial Hypercholesterolemia Expert Forum (FAME) Study
    Yamashita, Shizuya
    Masuda, Daisaku
    Harada-Shiba, Mariko
    Arai, Hidenori
    Bujo, Hideaki
    Ishibashi, Shun
    Daida, Hiroyuki
    Koga, Nobuhiko
    Oikawa, Shinichi
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2022, 29 (05) : 608 - 638
  • [37] Visit-to-visit variability of lipid and cardiovascular events in patients with familial hypercholesterolemia
    Cao, Ye-Xuan
    Li, Liang
    Zhang, Hui-Wen
    Jin, Jing-Lu
    Liu, Hui-Hui
    Guo, Yuan-Lin
    Wu, Na-Qiong
    Zhu, Cheng-Gang
    Dong, Qian
    Xu, Rui-Xia
    Sun, Jing
    Li, Jian-Jun
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (07)
  • [38] ASSESSMENT OF THE PREVALENCE OF FAMILIAL HYPERCHOLESTEROLEMIA IN PATIENTS WITH PRIMARY HYPERLIPIDEMIA IN MOSCOW LIPID CLINIC
    Zubareva, M.
    Rozhkova, T.
    Gornyakova, N.
    Malyshev, P.
    Sergienko, I.
    ATHEROSCLEROSIS, 2019, 287 : E219 - E219
  • [39] The effect of lipid-lowering treatment on indices of MASLD in familial hypercholesterolemia patients
    Boutari, Chrysoula
    Rizos, Christos, V
    Liamis, George
    Skoumas, Ioannis
    Rallidis, Loukianos
    Garoufi, Anastasia
    Kolovou, Genovefa
    Sfikas, George
    Tziomalos, Konstantinos
    Skalidis, Emmanouil
    Kotsis, Vasileios
    Doumas, Michalis
    Stamatelopoulos, Kimon
    Lambadiari, Vaia
    Anagnostis, Panagiotis
    Boufidou, Amalia
    Giannakopoulou, Vasiliki
    Anastasiou, Georgia
    Petkou, Ermioni
    Vlachopoulos, Charalambos
    Dima, Ioanna
    Fakas, Georgios
    Papathanasiou, Konstantinos A.
    Attilakos, Achilleas
    Kolovou, Vana
    Koumaras, Charalambos
    Agapakis, Dimitrios
    Zacharis, Evangelos
    Antza, Christina
    Milionis, Haralampos
    Liberopoulos, Evangelos
    Mantzoros, Christos S.
    CLINICAL NUTRITION, 2024, 43 (12) : 84 - 91
  • [40] Reducing cardiovascular risk in patients with familial hypercholesterolemia: Risk prediction and lipid management
    Miname, Marcio H.
    Santos, Raul D.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2019, 62 (05) : 414 - 422
12345